tiprankstipranks
Trending News
More News >
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Income Statement

Compare
402 Followers

ADC Therapeutics Income Statement

Last quarter (Q3 2025), ADC Therapeutics's total revenue was $16.43M, a decrease of -11.03% from the same quarter last year. In Q3, ADC Therapeutics's net income was $-40.97M. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 70.84M$ 69.56M$ 209.91M$ 33.92M$ 0.00
Gross Profit
$ 64.89M$ 67.03M$ 206.61M$ 32.52M$ -141.82M
Operating Expenses
$ 195.54M$ 233.01M$ 329.95M$ 294.24M$ 77.45M
Depreciation and Amortization
$ 3.28M$ 3.27M$ 2.39M$ 2.63M$ 821.00K
EBITDA
$ -102.65M$ -145.83M$ -107.70M$ -230.53M$ -218.23M
Operating Income
$ -130.65M$ -165.99M$ -123.34M$ -261.72M$ -219.26M
Other Income/Expenses
$ -27.03M$ -34.96M$ -33.56M$ 10.21M$ -26.70M
Pretax Income
$ -157.68M$ -200.95M$ -156.90M$ -251.50M$ -245.96M
Net Income
$ -157.85M$ -240.05M$ -157.13M$ -230.03M$ -246.29M
Per Share Metrics
Basic EPS
$ -1.62$ -2.94$ -1.99$ -3.00$ -3.77
Diluted EPS
$ -1.62$ -2.94$ -1.99$ -3.00$ -3.77
Weighted Average Shares Outstanding
97.16M 81.71M 78.15M 76.75M 65.41M
Weighted Average Shares Outstanding (Diluted)
97.16M 81.71M 78.15M 76.75M 65.41M
Currency in USD

ADC Therapeutics Earnings and Revenue History